Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis

American Journal of Rhinology and Allergy

Volumn 25, Issue 1, 2011, Pages

  Ciebiada, Maciej ^a   Gorska Ciebiada, Malgorzata ^a   Barylski, Marcin ^a   Kmiecik, Tomasz ^a   Gorski, Pawel ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; DESLORATADINE; LEVOCETIRIZINE; MONTELUKAST;

ADULT; ARTICLE; CLINICAL ARTICLE; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; EVENING DOSAGE; FEMALE; HOUSE DUST ALLERGY; HUMAN; MALE; MONOTHERAPY; NOSE CONGESTION; PERENNIAL RHINITIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ACETATES; ADOLESCENT; ADULT; AGED; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; CETIRIZINE; DISEASE PROGRESSION; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; LEUKOTRIENE ANTAGONISTS; LORATADINE; MALE; MIDDLE AGED; NASAL OBSTRUCTION; PYROGLYPHIDAE; QUINOLINES; RHINITIS, ALLERGIC, PERENNIAL;

EID: 79551529499     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2011.25.3540     Document Type: Article

References (24)

1. Bousquet J, Van Cauwenberge P, and Khaltaev N. The Workshop Expert Panel. Allergic Rhinitis and its Impact on Asthma (ARIA). J Allergy Clin Immunol 86S:1-160, 2008.
2. Thomson L, Blaylock MG, Sexton DW, et al. Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells. Clin Exp Allergy 32:1187-1192, 2002. (Pubitemid 35007422)
3. Jerazawi E. Effect of levocetirizine on eotaxin induced eosinophil chemotaxis with and without interleukin 5 proming in vitro. Allergy 56(suppl 68):138, 2001.
4. Ciebiada M, Gorska-Ciebiada M, DuBuske LM, and Gorski P. Montelukast with desloratadine or levocetirizine for he treatment of persistent allergic rhinitis. Ann Allergy Asthma Immunol 97:664-671, 2006.
5. Nayak AS, and Schenkel E. Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis. Allergy 56:1077-1080, 2001. (Pubitemid 33020649)
6. Meltzer EO, Prenner BM, Nayak A, and the Desloratadine Study Group. Efficacy and tolerability of once daily 5 mg desloratadine an H1 receptor antagonist in patients with seasonal allergic rhinitis. Clin Drug Invest 21:25-32, 2001.
7. de Blic J, Wahn U, Billard E, et al. Levocetirizine in children: Evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. Pediatr Allergy Immunol 16:267-275, 2005.
8. Henz BM. The pharmacologic profile of desloratadine: A review. Allergy 56(suppl 65):7-13, 2001.
9. Ciebiada M, Górska Ciebiada M, and Górski P. Desloratadyna w leczeniu całorocznego alergicznego nieżytu nosa- wieloośrodkowe badania w Polsce. Alergia Astma Immunol 8:101-105, 2002.
10. Potter PC. Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitised to house dust mites. Allergy 58:893-899, 2003.
11. Ciebiada M, Gorska Ciebiada M, Kmiecik T, et al. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine. J Investig Allergol Clin Immunol 18:343-349, 2008.
12. van Adelsberg J, Philip G, Pedinoff AJ, et al. Montelukast improves symptoms of seasonal allergic rhinitis over a 4 week treatment period. Allergy 58:1268-1276, 2003. (Pubitemid 37487184)
13. Nayak AS, Philip G, Lu S, et al. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: A multicenter, randomized, double blind, placebo controlled trial performed in the fall. Ann Allergy Asthma Immunol 88:552-560, 2002.
14. Meltzer EO, Malmstrom K, Lu S, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo controlled clinical trial. J Allergy Clin Immunol 105:917-922, 2000.
15. Patel P, Philip G, Yang W, et al. Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis. Ann Allergy Asthma Immunol 95:551-557, 2005. (Pubitemid 43010482)
16. Prenner B, Anolik R, Danzig M, and Yao R. Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: Effects on nasal congestion. Allergy Asthma Proc 30:263-269, 2009.
17. McLeod RL, Mingo GG, Xu X, et al. Loratadine and montelukast administered in combination produce decongestion in an experimental feline model of nasal congestion. Am J Rhinol Allergy 23:e17-e22, 2009. (Epub September 18, 2009.)
18. Bachert C, Bousquet J, Canonica GW, et al., and the XPERT Study Group. Levocetirizine improves quality of life and reduces costs in long term management of persistent allergic rhinitis. J Allergy Clin Immunol 114:838-844, 2004.
19. Holmberg K, Tonnel AB, Dreyfus I, et al. Desloratadine releaves nasal congestion and improves quality-of-life in persistent allergic rhinitis. Allergy 64(11):1663-1670, 2009.
20. Simons FE, Prenner BM, and Finn A Jr, and Desloratadine Study Group. Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol 111:617-622, 2003.
21. Pasquali M, Baiardini I, Rogkakou A, et al. Levocetirizine in persistent allergic rhinitis and asthma: Effects on symptoms, quality of life and inflammatory parameters. Clin Exp Allergy 36:1161-1167, 2006. (Pubitemid 44342931)
22. Patou J, De Smedt H, van Cauwenberge P, and Bachert C. Pathophysiology of nasal obstruction and meta analysis of early and late effects of levocetirizine. Clin Exp Allergy 36:972-981, 2006.
23. Day JH, Briscoe MP, Ratz JD, et al. Onset of action of loratadine/montelukast in seasonal allergic rhinitis subjects exposed to ragweed pollen in the Environmental Exposure Unit. Allergy Asthma Proc 30:270-276, 2009.
24. Ratner PH, Lim JC, and Georges GC. Comparison of once daily ebastine 20 mg ebastine 10 mg loratadine 10 mg and placebo in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 105:1101-1107, 2000.